Surgical Navigation Systems in Ohio

Mammotome is a global breast care company specializing in diagnostic and surgical solutions for breast cancer detection and treatment. The company manufactures vacuum-assisted breast biopsy systems, stereotactic biopsy devices, MR-guided biopsy platforms, and surgical marker navigation systems. Product portfolio includes the Mammotome PrimaTM MR System (in-room, vacuum-assisted MR breast biopsy), Mammotome RevolveTM and RevolveTM ST stereotactic biopsy systems, Mammotome DualCoreTM and Elite systems, Pintuition® surgical marker navigation system, Neoprobe® GDS gamma detection system, and comprehensive biopsy site markers (HydroMARKTM Plus, standard markers). The company serves 60 countries with 550+ associates across 9 global locations. Mammotome holds FDA clearances for its MR biopsy systems and markers, and Health Canada approval for the Pintuition® System. As a Danaher-owned company, Mammotome integrates advanced imaging compatibility and procedural efficiency into products designed for radiologists, surgeons, and pathologists in hospital and outpatient diagnostic centers.

GuidedSMILE is a dental technology innovator specializing in digital, full-arch guided reconstruction systems for All-On-X implant surgeries. The company's flagship CHROME GuidedSMILE system enables dentists to perform preplanned surgical procedures with precision using patented anchored, stackable metal guides and fixation bases. The system delivers anchored bone reduction, site drilling guidance, abutment placement, and immediate-load prosthetics—all from a single surgical protocol. Components include Pin Guides, Fixation Bases, Osteotomy Guides, Carrier Guides, and integrated provisional prosthetics. GuidedSMILE collaborates with over 40 dental laboratories nationwide, supporting more than 10,000 full-arch cases annually. The workflow minimizes conversion time, eliminates bind-and-bend procedures, and provides complete surgical and restorative documentation transfer. Ideal for oral surgeons, implant dentists, and maxillofacial specialists seeking predictable, efficient full-arch reconstruction.

MediView XR, Inc. is a clinical augmented reality med-tech company specializing in first-in-class AR-powered visualization and navigation solutions for image-guided surgical and interventional procedures. The company develops mixed-reality platforms that overlay real-time 3D anatomical data, live ultrasound imaging, and procedural guidance directly into the surgeon's field of view via holographic heads-up displays. MediView's flagship products—OmnifyXR® Interventional Suite and XR90™ Holographic Surgical Navigation System—enable minimally invasive, ultrasound-guided soft tissue and bone procedures with improved ergonomics, workflow efficiency, spatial visualization depth, and real-time collaborative remote consultation and proctoring capabilities. The XR90 is FDA 510(k)-cleared and integrates seamlessly with GE HealthCare's Allia interventional imaging platform. Primary markets include interventional radiology, minimally invasive surgery, orthopedic surgery, and urological procedures. The company partners with leading academic medical centers and hospitals including The Cleveland Clinic, Mayo Clinic, NewYork Presbyterian/Weill Cornell Medicine, Memorial Sloan Kettering, and Ohio State University. MediView is Microsoft Gold partner and member of the American Medical Extended Reality Association. Recent Series A funding of $24M was led by GE HealthCare, Mayo Clinic, and Cleveland Clinic.

Centerline Biomedical develops intraoperative navigation technology for endovascular and interventional procedures. The company's flagship product, IOPS® (Intra-Operative Positioning System), is a 510(k)-cleared navigation platform that provides real-time 3D color image guidance as an alternative to conventional X-ray fluoroscopy. IOPS® is designed to mitigate occupational and patient radiation exposure in interventional cardiology, vascular surgery, and complex endovascular procedures. The system offers interactive navigation, high-quality 3D imaging, and portability compared to traditional 2D fluoroscopy-based guidance. Clinical evidence presented on the site documents significant occupational hazards associated with fluoroscopy exposure, including radiation-induced cataracts, brain tumors, and orthopedic issues among interventionalists. IOPS® targets procedures estimated at 4 million annually in the United States. The company collaborates with major medical institutions including Cleveland Clinic, the U.S. Air Force 59th Medical Wing, and the U.S. Army Institute of Surgical Research, indicating validation in both civilian and military surgical settings. The technology is positioned for vascular surgeons, interventional cardiologists, and trauma surgeons performing endovascular therapy, aortic procedures, and complex case management where radiation dose is a clinical and occupational concern.

Surgical Theater, Inc. develops eXperiential Reality (XR) platforms that transform 2D medical imaging (MRI, CT, DTI) into interactive 3D surgical models using AI-driven reconstruction technology. The company serves neurosurgery, spine surgery, and otolaryngology specialties with three primary solutions: PlanXR™ for preoperative surgical planning and rehearsal; Brain STORM™ for epilepsy care management; and SyncAR® (Spine and Cranial variants) for real-time intraoperative augmented reality visualization. Additional products include XR Studio™ for multidisciplinary case reviews and education within XR headsets, and ConveyXR™ for patient engagement and informed consent. The platform enables surgeons to visualize patient-specific anatomy, identify critical structures (nerves, blood vessels), and simulate complex procedures before entering the operating room. Deployed at leading academic medical centers including Mayo Clinic, Stanford, Mount Sinai, Houston Methodist, UCSF, and NYU Langone, among others. The technology derives from advanced flight simulation methodologies applied to surgical visualization. Regulatory status and specific FDA clearances not explicitly stated on fetched content, though clinical research studies referenced. Serves both academic and community hospital markets internationally.